Does this 8-K disclose new financial results or material events?

No. The filing is a Regulation FD disclosure under Item 7.01 that attaches the investor presentation for the Barclays Americas Select Franchise Conference. It does not report new earnings, and the information is furnished rather than filed for purposes of Section 18 of the Exchange Act.

What drove the year-over-year decline in 1Q24 earnings?

GAAP net income fell 35% YoY to $334M, mainly because net interest income dropped 12% to $1.44B as deposit costs rose and the NIM compressed from 3.29% to 2.90%. Noninterest expense rose 5% YoY, and the efficiency ratio deteriorated to 69.3% from 60.9%, partly reflecting Private Bank investment and Non-Core drag. Provision expense was steady at $171M.

How solid is CFG's capital and liquidity position?

Per the presentation, the CET1 ratio is 10.6% under current rules, or 8.9% adjusted for AOCI opt-out removal, which management says is among the strongest in the peer group. The pro forma LCR is 120% under Category I bank requirements, against a 100% minimum. Management expects the two CET1 measures to converge to 10.0-10.5% over the medium term.

What is the outlook for net interest margin and profitability?

Management targets a medium-term NIM of 3.25-3.40%, up from 2.91% in 1Q24, citing a ~62 bps tailwind from Non-Core runoff and receive-fixed swaps by 4Q27, partly offset by a 15-25 bps asset sensitivity drag. It also targets ~16-18% ROTCE over the medium term. These projections assume Fed Funds near 5% at YE2024 falling toward 3.50% by YE2027, and they are forward-looking and subject to rate and execution risk.

Are there credit quality concerns investors should watch?

The presentation describes credit as in line with expectations and well reserved, with ACL coverage of 1.61% and a 10.6% reserve on the general office book. Commercial real estate is $28.9B and office is $5.7B, with general office at $3.4B. Leveraged loans are a small share at ~1.7% of total loans. Investors should still monitor the CRE office exposure and the commercial book, which is $72.8B and about 51% of total loans.

CITIZENS FINANCIAL GROUP INC/RI 8-K: Regulation FD

01—Abstract

Summary

Summary of the 8-K filed May 8, 2024. Cited figures are marked; the original filing is the authoritative source.

Citizens Financial Group (CFG) furnished an 8-K under Item 7.01 (Regulation FD) on May 8, 2024, attaching a presentation Chairman and CEO Bruce Van Saun delivered at the Barclays Americas Select Franchise Conference.

The filing itself contains no new financial results; its substance is the investor deck, which reaffirms a medium-term outlook of roughly 16-18% ROTCE, a net interest margin target of 3.25-3.40%, and a set of strategic initiatives (Private Bank, NYC Metro expansion, private capital coverage, and the TOP 9 efficiency program). The deck emphasizes balance sheet strength: a 10.6% CET1 ratio (8.9% adjusted for AOCI opt-out removal, with both expected to converge to 10.0-10.5% over the medium term), a pro forma LCR of 120%, an ACL coverage ratio of 1.61%, and a deposit base of $176B^a that is 68% Consumer Banking and about 70% insured or secured. The key earnings context in the appendix is 1Q24 GAAP net income of $334 million ($0.65 diluted EPS), down 35% year over year, with the efficiency ratio at 69.3% and an ROTCE of 8.9%.

Management attributes much of the drag to the Private Bank investment (expected to reach breakeven in 2H24) and to the Non-Core portfolio, which is running off at about $1.2B^b per quarter in 1Q24. Management argues that a significant NII tailwind from the Non-Core runoff and receive-fixed swaps, about 62 bps of NIM uplift by 4Q27 (partly offset by roughly 15-25 bps of asset sensitivity), will drive relative outperformance in 2025-2027. That tailwind is a forward-looking assumption tied to a Fed Funds path of about 5% at YE2024 falling toward 3.50% by YE2027.

Credit appears stable by management's account: the commercial book is $72.8B^c with leveraged loans around 1.7% of total CFG loans, retail is $70.4B and predominantly super-prime/prime, and the general office reserve is 10.6%. Investors should weigh these management assertions against the forward-looking nature of the NIM and ROTCE targets, which are explicitly subject to rate, credit, and regulatory risks. Because the filing is a presentation furnished under Regulation FD, its content is not deemed filed under Section 18 of the Exchange Act.

02—Key points

Key Highlights

1Q24 GAAP net income was $334M ($0.65 diluted EPS), down 35% YoY from $511M, with the efficiency ratio at 69.3% and ROTCE at 8.9%.
Capital is strong: CFG CET1 is 10.6% (among the highest in the peer group), or 8.9% adjusted for AOCI opt-out removal, with management expecting both to converge to 10.0-10.5% over the medium term.
Medium-term targets include a ~16-18% ROTCE and a NIM range of 3.25-3.40%, up from the 1Q24 NIM of 2.91%, driven by an expected ~62 bps NIM tailwind from Non-Core runoff and receive-fixed swaps by 4Q27.
Deposit base of $176B is retail-oriented (68% Consumer Banking) with ~70% insured or secured; cumulative IB deposit beta of 52% is slightly better than the peer median.
The Private Bank is a current drag (net investment position) and is expected to reach breakeven in 2H24, with a longer-term target of 20%+ ROTCE.
Credit metrics are described as in line with peers: ACL coverage of 1.61%, a 10.6% general office reserve, super-prime/prime retail (~95% above 680 FICO), and leveraged loans at ~1.7% of total CFG loans.
The Non-Core portfolio ran off $1.2B in 1Q24 and is fully funded with high-cost FHLB, collateralized auto debt, and brokered CDs, weighing on near-term results (Non-Core contributed a net loss of $60M underlying after tax).

03—Questions

Frequently Asked Questions

Does this 8-K disclose new financial results or material events?
No. The filing is a Regulation FD disclosure under Item 7.01 that attaches the investor presentation for the Barclays Americas Select Franchise Conference. It does not report new earnings, and the information is furnished rather than filed for purposes of Section 18 of the Exchange Act.
What drove the year-over-year decline in 1Q24 earnings?
GAAP net income fell 35% YoY to $334M, mainly because net interest income dropped 12% to $1.44B as deposit costs rose and the NIM compressed from 3.29% to 2.90%. Noninterest expense rose 5% YoY, and the efficiency ratio deteriorated to 69.3% from 60.9%, partly reflecting Private Bank investment and Non-Core drag. Provision expense was steady at $171M.
How solid is CFG's capital and liquidity position?
Per the presentation, the CET1 ratio is 10.6% under current rules, or 8.9% adjusted for AOCI opt-out removal, which management says is among the strongest in the peer group. The pro forma LCR is 120% under Category I bank requirements, against a 100% minimum. Management expects the two CET1 measures to converge to 10.0-10.5% over the medium term.
What is the outlook for net interest margin and profitability?
Management targets a medium-term NIM of 3.25-3.40%, up from 2.91% in 1Q24, citing a ~62 bps tailwind from Non-Core runoff and receive-fixed swaps by 4Q27, partly offset by a 15-25 bps asset sensitivity drag. It also targets ~16-18% ROTCE over the medium term. These projections assume Fed Funds near 5% at YE2024 falling toward 3.50% by YE2027, and they are forward-looking and subject to rate and execution risk.
Are there credit quality concerns investors should watch?
The presentation describes credit as in line with expectations and well reserved, with ACL coverage of 1.61% and a 10.6% reserve on the general office book. Commercial real estate is $28.9B and office is $5.7B, with general office at $3.4B. Leveraged loans are a small share at ~1.7% of total loans. Investors should still monitor the CRE office exposure and the commercial book, which is $72.8B and about 51% of total loans.

04—Continue

← View all 8-K filings